SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-177455"
 

Sökning: id:"swepub:oai:DiVA.org:uu-177455" > Genotype-phenotype ...

  • Lindahl, KatarinaUppsala universitet,Metabola bensjukdomar (författare)

Genotype-phenotype correlations and pharmacogenetic studies in 140 Swedish families with osteogenesis imperfecta

  • Artikel/kapitelEngelska2012

Förlag, utgivningsår, omfång ...

  • Elsevier BV,2012
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-177455
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-177455URI
  • https://doi.org/10.1016/j.bone.2012.02.332DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:124711049URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:vet swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Objective: Osteogenesis imperfecta (OI) is a rare heterogeneous disease of connective tissue leading to varying degrees of bone fragility. The worst form (type II) is peri-natally lethal whereas the mildest form (type I) is compatible with a normal life span. Over 1000 mutations causing OI have been described in the genes encoding collagen type I. As COL1A1 and COL1A2 are large genes, there are still many codon positions where no mutations have been reported and only a fraction of theoretically possible glycine substitutions have been described. In this study the spectrum of mutations causing OI in Sweden will be investigated and genotype–phenotype correlations as well as pharmacogenetics will be studied. Method: All patients with OI cared for at the Uppsala Osteoporosis Unit (Uppsala University Hospital) or Astrid Lindgren's Paediatric Hospital (Karolinska Institutet, Stockholm) were offered to enter the study. Patients from 140 unrelated families with OI accepted participation; 77 type I, 34 type IV, 20 type III, 5 without previous diagnosis and 4 with unclear OI type. Extensive clinical data is currently being collected on enrolled patients. Exons and flanking intron sequences of COL1A1 and COL1A2 are being sequenced in these families. Results: So far 133/140 families have been completely analyzed and in 27 no mutation was found. A total of 120 mutations have been detected, of which 104 are of a typical OI-type. In COL1A1 73 mutations were found and in COL1A2 31 mutations were noted. In 7 families 2 mutations were present, but only one of these was a typical OI-causing mutation. To date 16 amino acid changing mutations that were not of a typical OI-causing type have been noted and the majority of these have an unclear significance. Calculations of delta BMD Z-score response to bisphosphonate treatment did not show a difference in treatment response between groups with different types of OI or between patients with OI type I due to a qualitative vs. a quantitative collagen type I defect. Conclusion: The spectrum of mutations causing OI described in this Swedish cohort is of the expected type, with the exception of the amino acid changing mutations. It is notable that in seven families two separate mutations were identified. Calculations do not support a mutation dependent response to bisphosphonate treatment.

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Rubin, Carl-JohanUppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi(Swepub:uu)carub021 (författare)
  • Astrom, E. (författare)
  • Malmgren, B. (författare)
  • Kindmark, AndreasUppsala universitet,Metabola bensjukdomar(Swepub:uu)andrkind (författare)
  • Ljunggren, ÖstenUppsala universitet,Metabola bensjukdomar(Swepub:uu)osteljun (författare)
  • Uppsala universitetMetabola bensjukdomar (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Bone: Elsevier BV50, s. S109-S1098756-32821873-2763

Internetlänk

Hitta via bibliotek

  • Bone (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy